Certification is a compulsory independent assessment procedure for the quality and safety of care in public and private hospitals. It is conducted every 4 years by professionals (peers) appointed by the HAS (surveyors).

In accordance with HAS’ activity in supporting public authorities in vaccination policy-making, the committee is tasked with preparing the HAS’ Board deliberations, particularly with regards to: - Vaccine recommendations, including urgent Ministry of Health requests; - French Vaccination schedule set by the Ministry of Health; - Minimal disclosures required in publicity campaigns for vaccines.

The Economic and Public Health Committee ( Commission d’évaluation économique et de santé publique , CEESP) issues public health recommendations and technology appraisals based on clinical and economic evidence as well as on other domains (e.g. ethics, organisation). Technology is inclusive of medicinal products and devices, diagnostic and therapeutic techniques, systems of care, screening tools, etc. The committee also reviews single technology assessments from manufacturers and issues opinions on their efficiency, referred to as “efficiency opinion” in HAS publications. The CESSP can be commissioned by an external institution or by the College of HAS. It works in collaboration with other HAS committees.

The National Committee for the Evaluation of Medical Devices and Health Technologies ( Commission nationale d’évaluation des dispositifs médicaux et des technologies de santé, CNEDiMTS) examines questions relating to the evaluation of certain medical devices, medical procedures and other health technologies, with a view to their reimbursement by the health insurance scheme, and to their proper use.

The Transparency Committee (CT – Commission de la Transparence ) is a scientific body made up of doctors, pharmacists and specialists in methodology and epidemiology. It evaluates drugs that have been granted marketing authorization, when the laboratory marketing them wishes to obtain their inclusion on the list of reimbursable drugs. Its tasks include : -  Assesses medicinal products with Marketing Authorisation -  Provides recommendations for medicinal products -  Contributes to the proper use of medicinal products

HAS Board, management

An independent public scientific body, the French National Authority for Health (HAS) is tasked with further developing quality for the country's health and social care services. Established by legislation in August 2004, HAS works alongside public authorities to inform policy decisions and with health care professionals to optimize practices, organizations and services.